Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Georgetown University Medical Center, Washington, DC, United States

Survival: 7.9 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: United States
City/State/Province: Washington, DC
Hospital: Georgetown University Medical Center
Journal: Link
Date: 10/2002

Patients: This Phase II study involved 32 patients with advanced (stage IIIB or IV or recurrent) non-small-cell lung cancer. None of the patients had received prior chemotherapy.

Treatment: The treatment consisted of the administration of two drugs, gemcitabine (gemzar) and docetaxel (taxotere).

Toxicity: Toxicities included grade 4 hematological toxicity, and grade 3 or less fatigue, anorexia, nausea, fluid retention, transaminitis, diarrhea, myalgias, pneumonitis, and peripheral neuropathy.

Results: The median survival time was 7.9 months.

Support: This study was supported in part by Aventis and Lilly, and two of the study’s authors have received honoraria from these companies.

Correspondence: Naiyer Rizvi, MD

E-mail to a Friend Email Physician More Information